This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Seidl, R. Articles by Lubec, G. Search for Related Content PubMed PubMed Citation Articles by Seidl, R. Articles by Lubec, G. Social Bookmarking                         What's this?

Evidence for Apoptosis in the Fetal Down Syndrome Brain

Department of Pediatrics University of Vienna, Vienna, Austria

Bettina Bidmon, MD

Department of Pediatrics University of Vienna, Vienna, Austria

Michael Bajo, PhD

Department of Pediatrics University of Vienna, Vienna, Austria

Byon C. Yoo, PhD

Department of Pediatrics University of Vienna, Vienna, Austria

Nigel Cairns, PhD

Brain Bank Institute of Psychiatry, University of London, London, England

Eric C. LaCasse, MD

Apoptogen Inc CHEO Research Institute, Ottawa, Ontario, Canada

Gert Lubec, MD, CChem, FRSC

Department of Pediatrics University of Vienna, Vienna, Austria, gert.lubec{at}akh-wien.ac.at

In Down syndrome, enhanced apoptosis (programmed cell death) may play a role in the pathogenesis of characteristic early mental retardation and precocious neurodegeneration of Alzheimer type. Various apoptosis-associated proteins (Bax, Bcl-2, Fas, p53, Hsp70, neuronal apoptosis inhibitory protein-like immunoreactivity) were investigated in four different cortical regions and the cerebellum of one fetal Down syndrome (35 weeks' gestation) postmortem brain sample compared with a control brain sample. The most impressive finding was an at least fivefold elevation of Bax protein together with decreased Bcl-2 values in all Down syndrome cerebral regions investigated. In addition, antiapoptotic, presumably caspase-inhibitory, principles like heat shock protein 70 and neuronal apoptosis inhibitory protein were also reduced. Whereas Fas protein, an important member of receptor-mediated apoptosis, was inconsistently altered, a rather surprising finding was reduced proapoptotic, regulatory protein p53 in four of five regions. The findings are in good agreement with the proposed role of the Bcl-2 protein family in regulating developmental (naturally occurring) apoptotic neuronal death and further suggest that developmental apoptosis may be inappropriately commandeered by so far undefined pathologic processes in Down syndrome. (J Child Neurol 2001;16:438-442).

Journal of Child Neurology, Vol. 16, No. 6, 438-442 (2001)
DOI: 10.1177/088307380101600610


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				E.J. Wolvetang, T.J. Wilson, E. Sanij, J. Busciglio, T. Hatzistavrou, A. Seth, P.J. Hertzog, and I. Kola ETS2 overexpression in transgenic models and in Down syndrome predisposes to apoptosis via the p53 pathway Hum. Mol. Genet., February 1, 2003; 12(3): 247 - 255. [Abstract] [Full Text] [PDF]